Skip to content 
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida. more
| Time Frame | SCNX | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -4.64% | 1.07% | 0.74% |
| 1-Month Return | -17.14% | 1.46% | 1.28% |
| 3-Month Return | -29.74% | 3.51% | 3.6% |
| 6-Month Return | -63.3% | 15.29% | 7.31% |
| 1-Year Return | -85.58% | 7.7% | 11.97% |
| 3-Year Return | -92.46% | 21.02% | 72.07% |
| 5-Year Return | -99.63% | 37.81% | 76.01% |
| 10-Year Return | -99.43% | 139.15% | 258.47% |
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 17.12M | 9.89M | 10.25M | 1.36M | 136.64K | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.76,"profit":true},{"date":"2022-12-31","value":59.86,"profit":true},{"date":"2023-12-31","value":7.97,"profit":true},{"date":"2024-12-31","value":0.8,"profit":true}] |
| Cost of Revenue | 11.42M | 5.14M | 4.73M | 1.31M | 130.64K | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":45.06,"profit":true},{"date":"2022-12-31","value":41.44,"profit":true},{"date":"2023-12-31","value":11.52,"profit":true},{"date":"2024-12-31","value":1.14,"profit":true}] |
| Gross Profit | 5.71M | 4.75M | 5.52M | 49.03K | 6.00K | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":83.16,"profit":true},{"date":"2022-12-31","value":96.71,"profit":true},{"date":"2023-12-31","value":0.86,"profit":true},{"date":"2024-12-31","value":0.11,"profit":true}] |
| Gross Margin | 33.33% | 47.99% | 53.85% | 3.60% | 4.39% | [{"date":"2020-12-31","value":61.9,"profit":true},{"date":"2021-12-31","value":89.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.68,"profit":true},{"date":"2024-12-31","value":8.16,"profit":true}] |
| Operating Expenses | 8.21M | 10.04M | 8.44M | 4.45M | 14.71M | [{"date":"2020-12-31","value":55.85,"profit":true},{"date":"2021-12-31","value":68.25,"profit":true},{"date":"2022-12-31","value":57.36,"profit":true},{"date":"2023-12-31","value":30.23,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Operating Income | (2.51M) | (5.29M) | (2.92M) | (4.40M) | (14.70M) | [{"date":"2020-12-31","value":-250666200,"profit":false},{"date":"2021-12-31","value":-529229300,"profit":false},{"date":"2022-12-31","value":-291596900,"profit":false},{"date":"2023-12-31","value":-439645100,"profit":false},{"date":"2024-12-31","value":-1470101500,"profit":false}] |
| Total Non-Operating Income/Expense | (58.78K) | (47.18K) | 197.31K | (5.23M) | (5.28M) | [{"date":"2020-12-31","value":-29.79,"profit":false},{"date":"2021-12-31","value":-23.91,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2648.34,"profit":false},{"date":"2024-12-31","value":-2675.06,"profit":false}] |
| Pre-Tax Income | (2.54M) | (5.32M) | (2.40M) | (8.48M) | (18.78M) | [{"date":"2020-12-31","value":-253605100,"profit":false},{"date":"2021-12-31","value":-531588300,"profit":false},{"date":"2022-12-31","value":-240344200,"profit":false},{"date":"2023-12-31","value":-848286400,"profit":false},{"date":"2024-12-31","value":-1877887600,"profit":false}] |
| Income Taxes | - | - | - | - | (534.40K) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-53439600,"profit":false}] |
| Income After Taxes | - | - | - | - | (18.24M) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-1824448000,"profit":false}] |
| Income From Continuous Operations | (2.54M) | (5.32M) | (2.40M) | (8.48M) | (18.24M) | [{"date":"2020-12-31","value":-253605100,"profit":false},{"date":"2021-12-31","value":-531588300,"profit":false},{"date":"2022-12-31","value":-240344200,"profit":false},{"date":"2023-12-31","value":-848286400,"profit":false},{"date":"2024-12-31","value":-1824448000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Net Income | (2.54M) | (5.32M) | (3.47M) | (17.84M) | 9.07M | [{"date":"2020-12-31","value":-27.97,"profit":false},{"date":"2021-12-31","value":-58.64,"profit":false},{"date":"2022-12-31","value":-38.3,"profit":false},{"date":"2023-12-31","value":-196.82,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
| EPS (Diluted) | (4.80) | (9.90) | (6.15) | (20.49) | 17.06 | [{"date":"2020-12-31","value":-28.14,"profit":false},{"date":"2021-12-31","value":-58.04,"profit":false},{"date":"2022-12-31","value":-36.05,"profit":false},{"date":"2023-12-31","value":-120.1,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| SCNX | |
|---|---|
| Cash Ratio | 0.05 |
| Current Ratio | 0.19 |
| Quick Ratio | 0.16 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| SCNX | |
|---|---|
| ROA (LTM) | -10.87% |
| ROE (LTM) | -24.07% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| SCNX | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.21 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.79 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| SCNX | |
|---|---|
| Trailing PE | 0.53 |
| Forward PE | 21.83 |
| P/S (TTM) | 24.87 |
| P/B | 0.21 |
| Price/FCF | NM |
| EV/R | 29.96 |
| EV/Ebitda | NM |
Scienture Holdings, Inc. (SCNX) share price today is $0.411
Yes, Indians can buy shares of Scienture Holdings, Inc. (SCNX) on Vested. To buy
Yes, you can purchase fractional shares of Scienture Holdings, Inc. (SCNX) via the Vested app. You can start investing in Scienture Holdings, Inc. (SCNX) with a minimum investment of $1.
You can invest in shares of Scienture Holdings, Inc. (SCNX) via Vested in three simple steps:
The 52-week high price of Scienture Holdings, Inc. (SCNX) is $3.61. The 52-week low price of Scienture Holdings, Inc. (SCNX) is $0.39.
The price-to-earnings (P/E) ratio of Scienture Holdings, Inc. (SCNX) is 0.5333
The price-to-book (P/B) ratio of Scienture Holdings, Inc. (SCNX) is 0.21
The dividend yield of Scienture Holdings, Inc. (SCNX) is 0.00%
The market capitalization of Scienture Holdings, Inc. (SCNX) is $16.43M
The stock symbol (or ticker) of Scienture Holdings, Inc. is SCNX
Consider the share price of Scienture Holdings, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Scienture Holdings, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Scienture Holdings, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Scienture Holdings, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Scienture Holdings, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Scienture Holdings, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
